SGO-话题@MedSci - 梅斯（MedSci）

#SGO#

26篇内容 | 1626人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2040158, encodeId=1eaf204015894, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=【预防接种日】人乳头瘤病毒（宫颈癌）疫苗接种的立场文件：来自欧洲妇科肿瘤学会- 欧洲阴道镜联盟（ESGO - EFC）, objectType=article, longId=206070, objectId=d7e92060e073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e92060e073, replyNumber=0, likeNumber=93, createdTime=2021-06-02, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e92060e073, moduleTitle=【预防接种日】人乳头瘤病毒（宫颈癌）疫苗接种的立场文件：来自欧洲妇科肿瘤学会- 欧洲阴道镜联盟（ESGO - EFC）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d7e92060e073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040160, encodeId=9f3c20401608f, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2020年欧洲妇科肿瘤学会(ESGO)晚期卵巢癌手术质量指标更新, objectType=article, longId=206085, objectId=4a9920608543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a9920608543, replyNumber=0, likeNumber=91, createdTime=2021-12-01, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a9920608543, moduleTitle=2020年欧洲妇科肿瘤学会(ESGO)晚期卵巢癌手术质量指标更新, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4a9920608543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040161, encodeId=fbdb204016198, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=指南速递 || 2020 ESGO/SIOPE指南：青少年和年轻人非上皮性卵巢癌的管理, objectType=article, longId=206089, objectId=567b2060892a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=567b2060892a, replyNumber=0, likeNumber=94, createdTime=2021-02-12, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=567b2060892a, moduleTitle=指南速递 || 2020 ESGO/SIOPE指南：青少年和年轻人非上皮性卵巢癌的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=567b2060892a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040159, encodeId=d3652040159b7, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=ESGO || 子宫内膜癌患者保留生育功能的临床建议, objectType=article, longId=206112, objectId=fb2b20611217, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb2b20611217, replyNumber=0, likeNumber=73, createdTime=2021-06-24, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb2b20611217, moduleTitle=ESGO || 子宫内膜癌患者保留生育功能的临床建议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fb2b20611217)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040157, encodeId=38a8204015efb, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2020 SGO临床实践声明：激素治疗（HT）在妇科肿瘤以及妇科肿瘤高危女性中的应用, objectType=article, longId=188783, objectId=e075188e8313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e075188e8313, replyNumber=0, likeNumber=73, createdTime=2020-07-17, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e075188e8313, moduleTitle=2020 SGO临床实践声明：激素治疗（HT）在妇科肿瘤以及妇科肿瘤高危女性中的应用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e075188e8313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040156, encodeId=41f82040156fe, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2020 SGO临床实践声明：大麻素类药物在癌症患者中的应用, objectType=article, longId=186662, objectId=a734186662e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a734186662e2, replyNumber=0, likeNumber=67, createdTime=2020-08-19, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a734186662e2, moduleTitle=2020 SGO临床实践声明：大麻素类药物在癌症患者中的应用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a734186662e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040155, encodeId=468c2040155aa, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2019 KSGO临床指南：9价HPV疫苗, objectType=article, longId=160475, objectId=7bf91604e5fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bf91604e5fb, replyNumber=0, likeNumber=56, createdTime=2019-08-30, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bf91604e5fb, moduleTitle=2019 KSGO临床指南：9价HPV疫苗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7bf91604e5fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040154, encodeId=622920401542f, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2017 JSGO指南：宫颈癌的治疗, objectType=article, longId=150609, objectId=614f15060954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=614f15060954, replyNumber=0, likeNumber=65, createdTime=2019-07-01, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=614f15060954, moduleTitle=2017 JSGO指南：宫颈癌的治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=614f15060954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040150, encodeId=73f4204015086, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=SGO 2018 | Pembrolizumab联合Niraparib使卵巢癌患者获益, objectType=article, longId=133818, objectId=c2551338183d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2551338183d, replyNumber=0, likeNumber=109, createdTime=2018-07-19, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2551338183d, moduleTitle=SGO 2018 | Pembrolizumab联合Niraparib使卵巢癌患者获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c2551338183d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040153, encodeId=8bf02040153d4, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2018 KSGO共识声明：卵巢癌的管理指南, objectType=article, longId=138797, objectId=b6d7138e97eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6d7138e97eb, replyNumber=0, likeNumber=86, createdTime=2018-06-24, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6d7138e97eb, moduleTitle=2018 KSGO共识声明：卵巢癌的管理指南, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b6d7138e97eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040148, encodeId=02db2040148f8, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2018年美国妇科肿瘤学年会（SGO）：重要研究结果荟萃（上）, objectType=article, longId=133558, objectId=8a3213355892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a3213355892, replyNumber=0, likeNumber=80, createdTime=2019-03-01, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a3213355892, moduleTitle=2018年美国妇科肿瘤学年会（SGO）：重要研究结果荟萃（上）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8a3213355892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040152, encodeId=ffbd204015297, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2018 ESGO/ESTRO/ESP指南：宫颈癌患者的管理, objectType=article, longId=136716, objectId=f2d6136e16b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2d6136e16b7, replyNumber=0, likeNumber=68, createdTime=2018-04-29, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2d6136e16b7, moduleTitle=2018 ESGO/ESTRO/ESP指南：宫颈癌患者的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f2d6136e16b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040149, encodeId=5d772040149a3, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2018 SGO：重要研究结果荟萃（下）, objectType=article, longId=133674, objectId=817e1336e4b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817e1336e4b7, replyNumber=0, likeNumber=80, createdTime=2018-11-23, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817e1336e4b7, moduleTitle=2018 SGO：重要研究结果荟萃（下）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=817e1336e4b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040151, encodeId=bf47204015115, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2018 SGO：宫颈癌常规筛查是否应将年龄延至65岁以上？, objectType=article, longId=134559, objectId=2c7a13455964, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c7a13455964, replyNumber=0, likeNumber=74, createdTime=2019-02-14, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c7a13455964, moduleTitle=2018 SGO：宫颈癌常规筛查是否应将年龄延至65岁以上？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2c7a13455964)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040145, encodeId=2d97204014582, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2016KSGO立场声明——腹膜，卵巢和输卵管癌的基因检测发布, objectType=article, longId=78108, objectId=b7e7e8108d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7e7e8108d5, replyNumber=0, likeNumber=57, createdTime=2016-11-05, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7e7e8108d5, moduleTitle=2016KSGO立场声明——腹膜，卵巢和输卵管癌的基因检测发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b7e7e8108d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040143, encodeId=3b75204014339, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=卵巢癌化疗和靶向治疗相关进展---美国妇科肿瘤学会(SGO)年会记录, objectType=article, longId=65933, objectId=d8c56593309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8c56593309, replyNumber=0, likeNumber=104, createdTime=2016-08-14, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8c56593309, moduleTitle=卵巢癌化疗和靶向治疗相关进展---美国妇科肿瘤学会(SGO)年会记录, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d8c56593309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040144, encodeId=f878204014463, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=图文说：Glasgow 评分，从入门到精通！, objectType=article, longId=70230, objectId=2a1be02303d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a1be02303d, replyNumber=0, likeNumber=65, createdTime=2016-12-01, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a1be02303d, moduleTitle=图文说：Glasgow 评分，从入门到精通！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2a1be02303d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040147, encodeId=066d204014e0c, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2015JSGO指南——卵巢癌（包括原发性腹膜癌和输卵管癌）的治疗发布, objectType=article, longId=79194, objectId=56b5e919417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56b5e919417, replyNumber=0, likeNumber=74, createdTime=2017-02-24, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56b5e919417, moduleTitle=2015JSGO指南——卵巢癌（包括原发性腹膜癌和输卵管癌）的治疗发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=56b5e919417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040146, encodeId=32442040146a2, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=2016SGO临床实践指南——新辅助化疗治疗新诊断晚期卵巢癌发布, objectType=article, longId=78934, objectId=7714e893496, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7714e893496, replyNumber=0, likeNumber=71, createdTime=2017-07-31, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7714e893496, moduleTitle=2016SGO临床实践指南——新辅助化疗治疗新诊断晚期卵巢癌发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7714e893496)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040142, encodeId=c849204014201, content=<a href='/topic/show?id=3cb21623358' target=_blank style='color:#2F92EE;'>#SGO#</a>, objectTitle=【干货】HPV可否成为宫颈癌筛查**方案（全新宫颈癌筛查攻略：ASCCP/SGO会议纪要）, objectType=article, longId=60988, objectId=b9f96098857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9f96098857, replyNumber=0, likeNumber=71, createdTime=2016-01-21, rootId=0, userName=tamgche, userId=674961, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9f96098857, moduleTitle=【干货】HPV可否成为宫颈癌筛查**方案（全新宫颈癌筛查攻略：ASCCP/SGO会议纪要）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b9f96098857)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SGO

2020-05-29

tamgche (审核中...)

前往app查看评论内容

#SGO#

【预防接种日】人乳头瘤病毒（宫颈癌）疫苗接种的立场文件：来自欧洲妇科肿瘤学会- 欧洲阴道镜联盟（ESGO - EFC）

2021-06-02

tamgche (审核中...)

前往app查看评论内容

#SGO#

2020年欧洲妇科肿瘤学会(ESGO)晚期卵巢癌手术质量指标更新

2021-12-01

tamgche (审核中...)

前往app查看评论内容

#SGO#

指南速递 || 2020 ESGO/SIOPE指南：青少年和年轻人非上皮性卵巢癌的管理

2021-02-12

tamgche (审核中...)

前往app查看评论内容

#SGO#

ESGO || 子宫内膜癌患者保留生育功能的临床建议

2021-06-24

tamgche (审核中...)

前往app查看评论内容

#SGO#

2020 SGO临床实践声明：激素治疗（HT）在妇科肿瘤以及妇科肿瘤高危女性中的应用

2020-07-17

tamgche (审核中...)

前往app查看评论内容

#SGO#

2020 SGO临床实践声明：大麻素类药物在癌症患者中的应用

2020-08-19

tamgche (审核中...)

前往app查看评论内容

#SGO#

2019 KSGO临床指南：9价HPV疫苗

2019-08-30

tamgche (审核中...)

前往app查看评论内容

#SGO#

2017 JSGO指南：宫颈癌的治疗

2019-07-01

tamgche (审核中...)

前往app查看评论内容

#SGO#

SGO 2018 | Pembrolizumab联合Niraparib使卵巢癌患者获益

2018-07-19

tamgche (审核中...)

前往app查看评论内容

#SGO#

2018 KSGO共识声明：卵巢癌的管理指南

2018-06-24

tamgche (审核中...)

前往app查看评论内容

#SGO#

2018年美国妇科肿瘤学年会（SGO）：重要研究结果荟萃（上）

2019-03-01

tamgche (审核中...)

前往app查看评论内容

#SGO#

2018 ESGO/ESTRO/ESP指南：宫颈癌患者的管理

2018-04-29

tamgche (审核中...)

前往app查看评论内容

#SGO#

2018 SGO：重要研究结果荟萃（下）

2018-11-23

tamgche (审核中...)

前往app查看评论内容

#SGO#

2018 SGO：宫颈癌常规筛查是否应将年龄延至65岁以上？

2019-02-14

tamgche (审核中...)

前往app查看评论内容

#SGO#

2016KSGO立场声明——腹膜，卵巢和输卵管癌的基因检测发布

2016-11-05

zhouqu_8 (审核中...)

前往app查看评论内容

#SGO#

卵巢癌化疗和靶向治疗相关进展---美国妇科肿瘤学会(SGO)年会记录

2016-08-14

tamgche (审核中...)

前往app查看评论内容

#SGO#

图文说：Glasgow 评分，从入门到精通！

2016-12-01

tamgche (审核中...)

前往app查看评论内容

#SGO#

2015JSGO指南——卵巢癌（包括原发性腹膜癌和输卵管癌）的治疗发布

2017-02-24

tamgche (审核中...)

前往app查看评论内容

#SGO#

2016SGO临床实践指南——新辅助化疗治疗新诊断晚期卵巢癌发布

2017-07-31

tamgche (审核中...)

前往app查看评论内容

#SGO#

【干货】HPV可否成为宫颈癌筛查**方案（全新宫颈癌筛查攻略：ASCCP/SGO会议纪要）

2016-01-21

科室
- - 订阅+
  - 更多科室
工具
服务